Cellebrite DI Ltd. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Cellebrite DI Ltd. (CLBT) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.00 per share for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-03.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-03-03
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-03-03 | |
| 2024-12-31 | $10.93 20-F · filed 2025-03-18 | |
| 2024-06-30 | $10.41 6-K · filed 2024-08-15 | |
| 2023-12-31 | $6440.00 20-F · filed 2024-03-21 | |
| 2023-06-30 | $4.96 6-K · filed 2023-09-01 | |
| 2022-12-31 | $6.27 20-F · filed 2023-04-27 | |
| 2022-06-30 | $6.50 6-K · filed 2022-09-13 | |
| 2021-12-31 | $5.04 20-F · filed 2022-03-29 | |
| 2020-12-31 | $2.21 20-F · filed 2022-03-29 |